MedTrace Logo

Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma

NCT01151748 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2012-05-14

No results posted yet for this study

Summary

Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma

Conditions

  • Retinoblastoma
  • Eye Cancer

Interventions

PROCEDURE

Intra-arterial infusion of chemotherapy

Sponsors & Collaborators

Principal Investigators

  • Jonathan W Kim · Stanford University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01151748 on ClinicalTrials.gov